Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
9
Mins
30 Jun 2022
Low-Dose Dopamine in the Management of Intradialysis Hypotension: A Retrospective Cohort Study in Nigeria
Intradialysis hypotension (IDH) commonly complicates haemodialysis treatment, and could be associated with dysfunction…
10
Mins
30 Jun 2022
Pathophysiology of Diabetic Kidney Disease
Diabetic kidney disease (DKD) has been an immense burden on the healthcare system, and is the leading cause of end stage kidney disease…
6
Mins
30 Jun 2022
SGLT2 Inhibitors for Nephrologists
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are the mainstay of therapy for…
The unconscious mind of non-adherence
Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?
10
Mins
29 Jun 2022
Editor's Pick: Screening for Heart Disease in the Age of Digital Health Technologies: Who, When, and How?
This article will focus on how the emerging field of digital health technology can aid screening for heart disease and explore its usefulness in disease specific and population specific groups.
28 Jun 2022
Infographic: Obesity Increases Type 2 Diabetes Risk
Our latest EMJ Diabetes infographic depicts how obesity impacts the risk of developing Type 2 diabetes. Presenting key mechanisms that…
28 Jun 2022
Looking Upstream in IgAN: The Role of the Gut and Its Implications
Calliditas Therapeutics invite you to view this virtual symposium, which will discuss the current understanding of gut-kidney…
28 Jun 2022
Novartis-sponsored EULAR 2022 scientific symposium - Making the invisible visible in PsA and axSpA
In this symposium, Prof. Georg Schett, Prof. Denis Poddubnyy Dr. Raj Sengupta and Prof. Maria-Antonietta D’Agostino discuss: Impact and…
6
Mins
28 Jun 2022
Congress Review: EuroPCR 2022
For the first time since 2020, EuroPCR welcomed over 700 colleagues to an in-person congress in Paris, France. Paris, often referred to as…
5
Mins
28 Jun 2022
Artificial Intelligence in Interventional Cardiology
ARTIFICIAL intelligence (AI) has begun to permeate and revolutionise interventional cardiology. Multimodality images, ECGs, electronic health
←
1
2
3
…
337
338
339
340
341
342
343
…
919
920
921
→